AMP
This work evaluates performance of Harbinger’s ctDNA-based multi-cancer early detection (MCED) test in obese individuals from Harbinger’s Cancer ORigin Epigenetics-Harbinger Health (CORE-HH) study. High performance for cancers that currently lack screening options suggest the potential for a non-invasive, equitable screening approach that could enable earlier cancer detection and intervention in underserved populations.
